Skip to main content
Log in

Serotonergic influence on the growth hormone response to clonidine in rat

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Administration of the alpha2-adrenoceptor agonist clonidine induces growth hormone (GH) release in rat and man. In the present study it is shown that the GH response to clonidine is weaker in rats exposed to depletion of both noradrenaline and serotonin (by means of reserpine or the combined treatment of FLA-63 and PCPA) than in animals exposed to noradrenaline depletion (by means of FLA-63) only. The possibility that an impaired serotonergic neurotransmission contributes to the blunted GH responses to clonidine observed in patients suffering from endogenous depression is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Andén N-E (1967) Effects of reserpine and tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system. Eur J Pharmacol 1: 1–5

    PubMed  Google Scholar 

  • Arnold MA, Fernstrom JD (1980) Administration of antisomatostatin serum to rats reverses the inhibition of pulsatile growth hormone secretion produced by injection of metergoline but not yohimbine. Neuroendocrinology 31: 194–199

    PubMed  Google Scholar 

  • Balldin J, Bolle P, Eden S, Eriksson E, Modigh K (1980) Effects of electroconvulsive shocks on growth hormone secretion induced by monoamine receptor agonists in reserpine-pretreated rats. Psychoneuroendocrinology 5: 329–337

    PubMed  Google Scholar 

  • Bluet-Pajot MT, Schaub C, Mounier F, Segalen A, Duhault J, Kordon C (1980) Monoaminergic regulation of growth hormone in rat. J Endocrinol 94: 387–396

    Google Scholar 

  • Casanueva FF, Villanueva L, Cabranes JA, Cabezas-Cerrato J, Fernandez-Cruz A (1984) Cholinergic mediation of growth hormone secretion elicited by arginine, clonidine, and physical exercise in man. J Clin Endocrinol Metab 59: 526–530

    PubMed  Google Scholar 

  • Charney DS, Heninger GR, Sternberg G (1982) Failure of chronic antidepressant treatment to alter growth hormone response to clonidine. Psychiatry Res 7: 135–138

    PubMed  Google Scholar 

  • Checkley SA, Slade AP, Shur E (1981) Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 138: 51–55

    PubMed  Google Scholar 

  • Collu R, Fraschini F, Visconti P, Martini L (1972) Adrenergic and serotonergic control of growth hormone secretion in male rats. Endocrinology 90: 1231–1237

    PubMed  Google Scholar 

  • Delitala G, Maioli M, Pacifico A, Brianda S, Palerom M, Manelli M (1983) Cholinergic receptor control mechanisms for L-Dopa, apomorphine, and clonidine-induced growth hormone secretion in man. J Clin Endocrinol Metab 57: 1145–1149

    PubMed  Google Scholar 

  • Durand D, Martin JB, Brazeau P (1977) Evidence for a role of alpha-adrenergic mechanisms in regulation of episodic growth hormone secretion in the rat. Endocrinology 100: 722–728

    PubMed  Google Scholar 

  • Edén S (1978) The secretory pattern of growth hormone: an experimental study in the rat. Acta Physiol Scand [suppl] 458

    Google Scholar 

  • Edén S, Bolle P, Modigh K (1979) Monoaminergic control of episodic growth hormone secretion in the rat: effect of reserpine, alpha-methyl-p-tyrosine, p-chloro-phenyl-alanine and haloperidol. Endocrinology 105: 523–529

    PubMed  Google Scholar 

  • Edén S, Eriksson E, Martin JB, Modigh K (1981) Evidence for a growth hormone releasing factor mediating alpha-adrenergic influence on growth hormone secretion in the rat. Neuroendocrinology 33: 24–27

    PubMed  Google Scholar 

  • Edén S, Modigh K (1977) Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks. Brain Res 129: 379–384

    PubMed  Google Scholar 

  • Eikelboom R, Tannenbaum GS (1983) Effects of obesity-inducing ventromedial hypothalamic lesions on pulsatile growth hormone and insulin secretion: Evidence for the existence of a growth hormone-releasing factor. Endocrinology 112: 212–219

    PubMed  Google Scholar 

  • Eriksson E, Edén S, Modigh K (1982) Up- and down-regulation of central postsynaptic alpha-2 receptors reflected in growth hormone response to clonidine in the reserpine-pretreated rat. Psychopharmacology 77: 327–331

    PubMed  Google Scholar 

  • Ferland L, Labrie F, Jobin M, Arimura A, Schally AV (1976) Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion. Biochem Biophys Res Comm 68: 149–156

    PubMed  Google Scholar 

  • Florvall L, Corrodi H (1970) Dopamine-beta-hydroxylase inhibitors. Acta Pharm Suec 7: 7–22

    PubMed  Google Scholar 

  • Katakami H, Kato Y, Matsushita N, Imura H (1984) Effects of neonatal treatment with monosodium glutamate on growth hormone release induced by clonidine and prostaglandin El in conscious male rats. Neuroendocrinology 38: 1–5

    PubMed  Google Scholar 

  • Koe BK, Weissman A (1966) p-Chlorophenylalanine: A specific depletor of brain serotonin. J Pharmacol Exp Ther 154: 499–516

    PubMed  Google Scholar 

  • Krulich L, Mayfield MA, Steele MK, McMillan BA, McCann SM, Koenig JI (1982) Differential effects of pharmacological manipulations of central alpha1 and alpha2-adrenergic receptors on the secretion of thyrotropin and growth hormone in male rats. Endocrinology 110: 796–804

    PubMed  Google Scholar 

  • Lal S, Tolis G, Martin JB, Brown GM, Guyda H (1975) Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. J Clin Endocrinol Metab 41: 827–832

    PubMed  Google Scholar 

  • Matussek N, Ackenheil M, Hippius H, Muller F, Schröder H-Th, Schultes H, Wailewski B (1980) Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry 2: 25–36

    PubMed  Google Scholar 

  • Miki N, Ono M, Shizume K (1984) Evidence that opiatergic and alpha-adrenergic mechanisms stimulate rat growth hormone release via growth hormone releasing factor. Endocrinology 114: 1950–1952

    PubMed  Google Scholar 

  • Murphy DL, Campbell L, Costa JL (1978) Current status of the indoleamine hypothesis of the affective disorder. In: Lipton MA, DiMascio A, Killam KE (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 1235–1248

    Google Scholar 

  • Negro-Vilar A, Ojeda SR, Advis JP, McCann SM (1979) Evidence for noradrenergic involvement in episodic prolactin and growth hormone release in ovariectomized rats. Endocrinology 105: 86–91

    PubMed  Google Scholar 

  • Siever LJ, Uhde TW, Silberman EK, Jimerson DC, Aloi JA, Post RM, Murphy DI (1982) Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Res 6: 171–183

    PubMed  Google Scholar 

  • Smythe GA, Duncan MW, Bradshaw JE, Cai WY (1982) Serotonergic control of growth hormone secretion: Hypothalamic dopamine, norepinephrine, and serotonin levels and metabolism in three hyposomatotropic rat models and in normal rats. Endocrinology 110: 376–383

    PubMed  Google Scholar 

  • Szabo M, Dudlak D, Thominet JL, Frohman LA (1983) Ectopic growth hormone-releasing factor stimulates growth hormone secretion in the urethane-anesthetized ratin vivo. Neuroendocrinology 37: 328–331

    PubMed  Google Scholar 

  • Tannenbaum GS, Ling N (1984) The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 115: 1952–1957

    PubMed  Google Scholar 

  • Terry LC, Martin JR (1981) Evidence for alpha-adrenergic regulation of episodic growth hormone and prolactin secretion in undisturbed male rat. Endocrinology 108: 1869–1873

    PubMed  Google Scholar 

  • Vale W, Vaughan J, Yamamoto G, Spiess J, Rivier J (1983) Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretionin vitro. Endocrinology 12: 1553–1555

    Google Scholar 

  • Wehrenberg WB, Ling N, Böhlen P, Esch F, Brazeau R, Guillemin R (1982) Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. Biochem Biophys Res Comm 109: 562–567

    PubMed  Google Scholar 

  • Wehrenberg WB, Bloch B, Chong-Li Z, Brazeau P, Ling N, Guillemin R (1984) Pituitary response to growth hormone-releasing factor in rats with functional or anatomical lesions of the central nervous system that inhibit endogenous growth hormone secretion. Regulat Peptid 8: 1–8

    Google Scholar 

  • Willoughby JO, Day TA (1981) Central catecholamine depletion: Effects on physiological growth hormone and prolactin secretion. Neuroendocrinology 32: 65–69

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Söderpalm, B., Andersson, L., Carlsson, M. et al. Serotonergic influence on the growth hormone response to clonidine in rat. J. Neural Transmission 69, 105–114 (1987). https://doi.org/10.1007/BF01244101

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01244101

Key words

Navigation